Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

Name: Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
License: Public Domain

Shandong Cancer Hospital and Institute

ClinicalTrials.gov · Datasets · License: Public Domain

immunotherapy, neoadjuvant therapy, resectable lung non-small cell carcinoma, biomarkers / blood

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444878
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.